22-41515521-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001098.3(ACO2):​c.670C>T​(p.Leu224Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.462 in 1,610,822 control chromosomes in the GnomAD database, including 181,559 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 12096 hom., cov: 31)
Exomes 𝑓: 0.47 ( 169463 hom. )

Consequence

ACO2
NM_001098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 3.87

Publications

37 publications found
Variant links:
Genes affected
ACO2 (HGNC:118): (aconitase 2) The protein encoded by this gene belongs to the aconitase/IPM isomerase family. It is an enzyme that catalyzes the interconversion of citrate to isocitrate via cis-aconitate in the second step of the TCA cycle. This protein is encoded in the nucleus and functions in the mitochondrion. It was found to be one of the mitochondrial matrix proteins that are preferentially degraded by the serine protease 15(PRSS15), also known as Lon protease, after oxidative modification. [provided by RefSeq, Jul 2008]
ACO2 Gene-Disease associations (from GenCC):
  • infantile cerebellar-retinal degeneration
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • optic atrophy 9
    Inheritance: Unknown, AD, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal recessive optic atrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 22-41515521-C-T is Benign according to our data. Variant chr22-41515521-C-T is described in ClinVar as Benign. ClinVar VariationId is 128257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACO2NM_001098.3 linkc.670C>T p.Leu224Leu synonymous_variant Exon 5 of 18 ENST00000216254.9 NP_001089.1 Q99798

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACO2ENST00000216254.9 linkc.670C>T p.Leu224Leu synonymous_variant Exon 5 of 18 1 NM_001098.3 ENSP00000216254.4 Q99798

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55803
AN:
151694
Hom.:
12097
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.413
Gnomad AMR
AF:
0.307
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.216
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.437
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.505
Gnomad OTH
AF:
0.355
GnomAD2 exomes
AF:
0.390
AC:
96698
AN:
247828
AF XY:
0.404
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.209
Gnomad ASJ exome
AF:
0.445
Gnomad EAS exome
AF:
0.177
Gnomad FIN exome
AF:
0.441
Gnomad NFE exome
AF:
0.500
Gnomad OTH exome
AF:
0.415
GnomAD4 exome
AF:
0.472
AC:
689110
AN:
1459010
Hom.:
169463
Cov.:
65
AF XY:
0.472
AC XY:
342680
AN XY:
725664
show subpopulations
African (AFR)
AF:
0.143
AC:
4786
AN:
33388
American (AMR)
AF:
0.219
AC:
9712
AN:
44404
Ashkenazi Jewish (ASJ)
AF:
0.449
AC:
11620
AN:
25888
East Asian (EAS)
AF:
0.290
AC:
11521
AN:
39680
South Asian (SAS)
AF:
0.388
AC:
33347
AN:
85938
European-Finnish (FIN)
AF:
0.444
AC:
23660
AN:
53296
Middle Eastern (MID)
AF:
0.365
AC:
2088
AN:
5714
European-Non Finnish (NFE)
AF:
0.510
AC:
566563
AN:
1110468
Other (OTH)
AF:
0.429
AC:
25813
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
21070
42140
63211
84281
105351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16046
32092
48138
64184
80230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.367
AC:
55784
AN:
151812
Hom.:
12096
Cov.:
31
AF XY:
0.363
AC XY:
26924
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.157
AC:
6505
AN:
41416
American (AMR)
AF:
0.307
AC:
4681
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
1601
AN:
3470
East Asian (EAS)
AF:
0.216
AC:
1111
AN:
5146
South Asian (SAS)
AF:
0.375
AC:
1803
AN:
4810
European-Finnish (FIN)
AF:
0.437
AC:
4599
AN:
10514
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.505
AC:
34255
AN:
67872
Other (OTH)
AF:
0.350
AC:
738
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1576
3152
4729
6305
7881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
536
1072
1608
2144
2680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.468
Hom.:
29633
Bravo
AF:
0.342
Asia WGS
AF:
0.278
AC:
969
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Sep 09, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 11, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Optic atrophy 9 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile cerebellar-retinal degeneration Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
9.8
DANN
Benign
0.75
PhyloP100
3.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799932; hg19: chr22-41911525; COSMIC: COSV53441563; COSMIC: COSV53441563; API